| Fund ID | 805-2342870426 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 16% |
| Owned by funds of funds | 18% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| West Street Capital Partners VIII Offshore, L.P. | Private Equity | $4.9B |
| West Street Capital Partners VIII, L.P. | Private Equity | $3.5B |
| West Street Capital Partners VII, L.P. | Private Equity | $2.97B |
West Street Life Sciences I Europe, Slp reports $70.1 million in gross assets, among the top 49% of private funds by size.
The stated minimum investment is $1 million.
West Street Life Sciences I Europe, Slp is managed by Goldman Sachs & Co. LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.